Global Subdural Hematoma Treatment Market, By Type (Acute Subdural Hematoma, Subacute Subdural Hematoma, Chronic Subdural Hematoma), Treatment (Anticonvulsants, Diuretics, Corticosteroids, Surgery, Catheter, Physical Therapy, Speech Therapy, Vitamin K Therapy, Others), Diagnosis (CT scan, MRI, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Seizures, Change in behavior, Headache, Nausea, Confusion, Dizziness, Vomiting, Lethargy, Apathy, Weakness, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.